期刊文献+

药物与择期经皮冠状动脉介入治疗对急性心肌梗死后MMP-1及TIMP-1的影响 被引量:1

Influence of drug treatment and selective percutaneous coronary intervention on MMP-1 and TIMP-1 in patients with acute myocardial infarction
暂未订购
导出
摘要 目的评价药物与择期经皮冠状动脉介入治疗(PCI)对急性心肌梗死(AMI)后基质金属蛋白酶-1(MMP-1)及其抑制物-1(TIMP-1)的影响。方法对2005年3月至2007年11月贵州省人民医院心内科的41例AMI患者在分别予强化内科药物(药物组,22例)和在此基础上行择期PCI介入(PCI组,19例)治疗。应用酶联免疫法检测AMI患者发病1周、3个月、6个月及12个月时的血清MMP-1和TIMP-1质量浓度。结果与对照组比较,药物组与PCI组各组MMP-1均显著降低;除12个月外,各时点组TIMP-1均显著降低(P<0.05)。两组组内比较,药物组12个月组TIMP-1较3个月及6个月组均显著升高(P<0.05)。两组同期各时点组比较,PCI组3个月及6个月TIMP-1较同期药物组显著升高,同时其6个月组MMP-1/TIMP-1比值较同期药物组显著降低(P<0.05)。结论从抑制原有胶原网络降解的角度而言,择期PCI在AMI后6个月内明显优于药物治疗,而至12个月时择期PCI未进一步显示出此方面的优越性。 Objective To evaluate influence of drug treatment and selective pereutaneous coronary intervention(PCI) on matrix metalloproteinase-1 (MMP-1)and tissue inhibitor of metalloproteinase-1 (TIMP-1)in patients with acute myocardial infarction (AMI). Methods According to the different therapies, forty-one patients with AMI were divided into two groups : drug treatment group ( drug group, n = 22 ) and selective PCI group ( PCI group, n = 19 ). The serum concentration of carboxy-terminal propeptide of MMP-1 and TIMP-1 of the patients with AMI were measured by euzyme-linked immunosorbent assay on the 1st week,the 3rd month and the 6th month and the 12th month after AMI. Results Compared to the control group, the serum concentration of MMP-1 in the patients was significantly decreased on the all times after AMI in the drug treatment group and selective PC/group, and the serum concentration of TIMP-1 in the patients was also significantly decreased on the 1 st week, the 3rd month, and the 6th month( P 〈 0.05 ). In the drug treatment group and selective PCI group,the level of TIMP-1 of the drug treatment group was significantly higher on the 12th month than those on the 3rd month and the 6th month ( P 〈 0. 05 ). The serum concentration of TIMP-1 of selective PCI group was significantly higher than those in the drug treatment group on the 3rd month and the 6th month (P 〈 0. 05 ). Meanwhile, the ratio of MMP-1/TIMP-1 in selective PCI group on the 6th month was lower than in the drug treatment group(P 〈 0. 05 ). Conclusion For inhibiting degradation of initially collagen lattice after AMI, selective PCI is better than drug treatment 6 months,while no significant differences are observed between drug treatment and selective PCI on the 12th month.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2008年第9期748-750,共3页 Chinese Journal of Practical Internal Medicine
基金 贵州省科学技术基金资助项目[黔基合计字(2003)3043] 贵州省高层次人才科研条件特助经费项目[黔人领函(2005)14]
关键词 心肌梗死 血管成形术 经腔 经皮冠状动脉 基质金属蛋白酶-1及其抑制物-1 myocardial infarction angioplasty, transluminal, percutaneous coronary MMP-1 and TIMP-1
  • 相关文献

参考文献8

二级参考文献44

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2急性心肌梗塞溶栓疗法参考方案(1996年7月修订)[J].中华心血管病杂志,1996,24(5):328-329. 被引量:1319
  • 3Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 4Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 5Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 7Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 8Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 9Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 10Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.

共引文献9317

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部